RNA sequencing has shown that ANKRD22 is specifically expressed in cancer stem cells in Krebs-2 ascites 36, and analysis by RNAi library screening has revealed that ANKRD22 can reduce the reprogramming efficiency of normal mouse embryonic fibroblasts 37. Here, ANKRD22 is linked to cancer.